Triptorelin (TRIP)

Sexual Health FDA approved

GnRH agonist used medically for prostate cancer and precocious puberty. Can restart HPTA when used appropriately.

Key Data

Research Status
FDA approved
Half-Life
3-5 hours (depot forms longer)
Administration
Intramuscular injection
Typical Dosage
100 mcg (single dose for HPTA)

Mechanism of Action

Initial GnRH receptor stimulation followed by downregulation with continued use.

Reported Benefits

All information is presented for Research Use Only (RUO). Not medical advice.

← All Peptides Dosing Calculator Community Forum Home